Pericarditis is the inflammation of the pericardial sac and accounts for 5% of visits to the emergency room for chest pain without myocardial infarction.

The patient experiences chest pain that is sharp, pleuritic and improves with sitting up and leaning forward.

Acute pericarditis is characterized by new-onset pericarditis with at least 2 of the following:

  • Pericarditic chest pain
  • Pericardial friction rubs
  • New or worsening pericardial effusion
  • ECG finding of a new diffuse ST-segment elevation or PR depression

Acute%20pericarditis Diagnosis


Acute Pericarditis

  • New-onset pericarditis with at least 2 of the following criteria:
    • Pericarditic chest pain
    • Pericardial friction rubs
    • New or worsening pericardial effusion
    • ECG finding of a new diffuse ST-segment elevation or PR depression
  • Additional supportive findings include elevated serum markers of inflammation and presence of pericardial inflammation from an imaging study (CT, CMR)

Recurrent Pericarditis

  • Occurs in 15-30% of patients after the documented initial episode of acute pericarditis and a symptom-free interval of ≥4-6 weeks
  • Usually presents within 18 months of the initial acute episode with similar findings and criteria for diagnosis

Incessant Pericarditis

  • Symptoms persisting for >4-6 weeks but <3 months with no clear-cut remission following the acute episode

Chronic Pericarditis

  • Disease process that lasts for >3 months


  • Initial evaluation should include screening for risk factors that would affect management plan
  • High-risk features for hospitalization (at least 1 of the following):
    • Fever >38°C
    • Subacute onset of symptoms (attributable to TB, uremia, neoplasm or collagen vascular disorders) developing over days or weeks
    • Large pericardial effusion
    • Cardiac tamponade
    • No response within 7 days to Aspirin or NSAIDs
    • Hypotension
    • Jugular venous distention
    • Trauma
    • Myopericarditis
    • Patients who are on anticoagulant therapy or are immunocompromised
  • Any clinical presentation that is suggestive of an underlying cause (eg bacterial, neoplastic or systemic inflammatory diseases) necessitates an etiology search and should also consider an epidemiological background check (ie TB prevalence)
    • An obligatory etiology workup is not required in all patients with acute pericarditis, particularly in areas with low TB prevalence, because the common causes of pericarditis are associated with a benign course and diagnostic studies reveal a low yield
    • Diagnostic work-up for suspected neoplastic or bacterial pericarditis may include surgical drainage or pericardiocentesis and percutaneous or surgical pericardial biopsy
    • Further testing is directed to specific etiologies according to clinical presentation


  • History taking should include the characteristics of the pain, patient’s medical history (ie history of cardiovascular, autoimmune or connective tissue diseases), smoking history and family history of cardiac diseases

Physical Examination

  • During physical exam, assess patient for changes in vital signs (eg tachycardia, decreased BP), elevated jugular venous pressure, pulsus paradoxus, presence of distant heart or abnormal lung sounds, peripheral edema

Laboratory Tests

  • It is recommended that the following work-up be done in all patients with suspected pericarditis:
    • Routine blood tests and serum markers of inflammation [eg C-reactive protein (CRP), ESR, WBC count] and myocardial injury (eg troponin, creatine kinase)
    • Thyroid, renal and liver function tests


  • Chest X-ray
  • Electrocardiogram (ECG)
  • Transthoracic echocardiography
  • Second-level investigative pericarditis work-up includes CT and/or cardiac magnetic resonance (CMR)

Differential Diagnosis

Alternative Diagnosis 

  • Conditions that present with chest pain need to be ruled out: Acute coronary syndromes, aortic dissection, myocardial ischemia or infarction, pneumonia, pulmonary embolism, pneumothorax, gastroesophageal reflux disease, gastric ulcer, tuberculosis, musculoskeletal disorders, herpes zoster and panic disorder
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 28 Jul 2020
The efficacy and cardiovascular (CV) safety of the SGLT2* inhibitor empagliflozin vs DPP-4** inhibitors and GLP-1*** receptor agonists in real-world patients were demonstrated in two interim analyses of the EMPRISE+ study presented at ADA 2020.
Roshini Claire Anthony, 3 days ago

Patients hospitalized with mild-to-moderate COVID-19 who are on angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for hypertension should continue these medications, according to primary results of the BRACE CORONA trial presented at ESC 2020.

Tristan Manalac, 09 Jul 2020
Left ventricular assist devices (LVADs) trigger almost immediate favourable metabolic changes in both diabetics and nondiabetics, according to a recent study.
Tristan Manalac, 04 Sep 2020
Anticoagulation therapy may be of value to patients with new-onset atrial fibrillation (AF) associated with sepsis, easing the risk of all-cause mortality and ischaemic stroke without increasing the likelihood of major bleeding, reports a study presented at the Digital 2020 Congress of the European Society of Cardiology (ESC).